Overview

An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children

Status:
Completed

Trial end date:
2004-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effectiveness and safety of OROS*methylphenidate/CONCERTA* vs. immediate release methylphenidate as a treatment for ADHD specifically for those children who have behavioural difficulties in the afternoon/after-school and evening periods.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen-Ortho Inc., Canada

Treatments:

Methylphenidate